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Abstract 
Purpose: To evaluate the effect of histone deacetylase (HDAC) inhibitor, trichostatin A (TCA), on 
cartilage regeneration in a rabbit perichondrial graft model. 
Methods: Perichondrial grafts (20 × 20 mm2) were derived from the ears of New Zealand rabbits and 
transplanted onto the paravertebral muscle of the face of each rabbit. The rabbits were separated into 
three groups: non-treated control group, vehicle-treated control group that received 0.3 mL of saline, 
and TCA-treated group administered 0.3 mL of TCA (500 ng/mL). Rabbits in all three groups were 
further divided into subgroups according to the duration of treatment after transplantation: 2, 4, 6, and 8 
weeks (n = 12 rabbits each). The effect of TCA on cartilage regeneration was determined histologically 
by evaluating the thickness of the cartilage plate in the grafted rabbits. 
Results: TCA increased the amount of immature cartilage 4 and 6 weeks after perichondrial graft 
implantation. Mature cartilage was seen in the TCA-treated rabbits 8 weeks after transplantation. The 
thickness of the cartilage plate was significantly (p < 0.01) higher in TCA group (905 ± 36) than in either 
the non-treated (632 ± 22) or the vehicle-treated control (639 ± 22) group.  
Conclusion: Treatment with trichostatin A, an HDAC inhibitor, enhances cartilage regeneration in rabbit 
recipients of a perichondrial graft. Furthermore, the findings of this study should be helpful in exploring 
the clinical use of trichostatin A. 
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The perichondrium is a connective tissue that 
supports the growth of cartilage. Several studies 
have shown that a perichondrial graft enhances 
cartilage repair and growth at anatomical 
locations including joints, the nasal septum, the 
larynx, and the ear [1,2]. The activity of 
chondrocytes is regulated by 
glycosaminoglycans and hyaluronic acid (HA), 
which enhance the secretion and synthesis of 
proteoglycans [3,4]. HA regenerates cartilage 
through mesenchymal signalling via fibrosis and 
scarring. The mechanisms underlying these 
processes include the inhibition of macrophage 
motility, the stimulation of lymphocyte migration 
and proliferation and granulocyte degranulation 
and phagocytosis [5].  
 
Histones are alkaline proteins present in all 
eukaryotic cells. Histone deacetylase (HDAC) 
inhibitors preserve the acetylated state of histone 
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and thereby alter gene expression; in turn, they 
thereby alter cellular migration, apoptosis, 
differentiation, and proliferation [6] as well as 
cellular functions such as fibrosis and 
angiogenesis [7,8]. The beneficial effects of 
HDAC inhibition in the therapeutic management 
of neurodegeneration, myelofibrosis, malignancy, 
and cystic fibrosis has been reported [9]. HDAC 
has also been implicated in cartilage 
regeneration and in chondrocyte hypertrophy 
[10]. Among the effects of the HDAC inhibitor 
trichostatin A (TCA) are accelerated embryonic 
development, increased stem cell differentiation, 
and potent anti-inflammatory and anti-cancer 
property activities [11–15]. TCA also enhances 
wound repair by increasing the acetylation of 
lysine in keratinocytes located at the wound site 
[16]. Based on these observations, the present 
study evaluated the chondrogenic effect of TCA 






The donor and recipient animals in this study 
were 2-month-old New Zealand rabbits (800 – 
1200 g). They were kept under standard 
laboratory conditions at room temperature (20–
25 °C) with a 12: 12-h light : dark cycle. The 
rabbits were allowed to acclimate to the lab for 
10 days before the start of the experiment. The 
protocols used in this study were approved by 
the Animal Ethical Committee of Tongji Medical 
College, Huazhong University of Science and 
Technology, China (no. TJM/ 2015/ 14) and the 
given study followed the guidelines of 
Association for the Assessment and 
Accreditation of Laboratory Animal Care 
International (AAALAC) for experimentation and 
animal use [17].  
 
Graft collection and implantation 
 
The rabbits were separated into three groups of 
12 each according to the different durations of 
treatment: 2, 4, 6 and 8 weeks. Surgery was 
performed in rabbits anaesthetised by an 
intramuscular injection of xylazine (5 mg/kg) and 
ketamine (35 mg/kg) followed by the prophylactic 
intramuscular injection of cefuroxime at a dose of 
30 mg/kg. The skin of the rabbits was sterilised 
before the operation, which began with a 
superficial incision of the ear skin. The skin was 
then withdrawn and a 20 × 20mm2 fragment of 
perichondrium was excised from its bed. The 
wound was sutured close using 5/0 braided 
polyglactin. The graft was then sutured into place 
on the paravertebal muscle of the face of each 
rabbit using monofilament polypropylene (6/0), 
ensuring that the graft was kept in a stretched 
position but without tension. The rabbits were 
separated into three groups: a non-treated 
control group, a vehicle-treated control group that 
received 0.3 mL of saline, and a TCA-treated 
group administered 0.3 mL of TCA (500 ng/mL). 
TCA and saline were injected beneath the 
perichondrial graft. Polyglactin sutures of 5/0 




Neochondrogenesis by the perichondrial graft 
was evaluated histologically 2, 4, 6 and 8 weeks 
after surgery. At each time point, rabbits from the 
different groups were euthanised, and tissue 
specimens were excised from the operative site. 
The specimens were fixed in 10 % formalin, 
dehydrated in a graded series of ethanol, and 
paraffin-embedded. Tissue sections of 10 mm 
thickness, prepared using a microtome, were 
stained with haematoxylin and eosin (H & E) and 
Masson’s trichrome. Light microscopy (400 ×) 
was used to evaluate the histology of the 
perichondrial graft according to the cellular 
content and cartilage thickness. The latter was 
measured at 10 different points using an ocular 
micrometer and the mean value was calculated. 
The pathologist evaluating the histology sections 




The results are expressed as mean ± standard 
deviations (n = 12). The data were analysed by a 
one-way ANOVA followed by Dunnett’s post-hoc 
test. P < 0.05 was considered to indicate 




Effect of TCA on cartilage growth 
 
Neocartilage development was not observed in 
either the control or the vehicle-treated group 
after 2 post-operative weeks, whereas immature 
cartilage was detected at the perichondrial graft 
site in the TCA treated group. At 4 and 6 weeks 
after surgery, the neocartilage development in 
the TCA-treated group increased further. Signs 
of inflammation and infection were not seen in 
any of the groups. In the two control groups, the 
chondrocytes were smaller and pyknotic, lacked 
vacuoles, and were sparsely distributed, whereas 
the cells were spherical and contained 
cytoplasmic vacuoles in the TCA treated group 
(Figure 1). 
 
After 8 weeks, mature chondrochytes were seen 
in all three groups, but the cartilage in both 
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control groups was much thinner than the 
cartilage of the TCA group (Figure 2). 
 
Effect of TCA on cartilage thickness 
 
The thickness of the cartilage in the TCA-treated 
rabbits 8 weeks after perichondrial 
transplantation was 905 mm, whereas it was 632 
and 639 mm in the non-treated and vehicle-
treated control groups, respectively. The 
difference between the TCA group and both 
control groups was significant (p < 0.01), 




Cartilage replacement is an essential aspect of 
orthopaedic, maxillofacial, and plastic surgery. 
The advantages of perichondrial grafting in the 
treatment of cartilage defects have been 
demonstrated in several experimental and 
clinical studies. The factors that promote 
cartilaginous differentiation from the 
perichondrium have also been examined [2]. The 
role of HDAC in cartilage regeneration and 
differentiation was previously described [18]. 
 
 
Figure 1: Effect of TCA on cartilage formation 4 weeks after the transplantation of a perichondrial graft (H&E, 
100 ×). A = non-treated control group; B = vehicle-treated control group; and C = TCA-treated group 
 
 
Figure 2: Effect of TCA on cartilage formation 8 weeks after transplantation of a perichondrial graft (Masson’s 
trichrome, 100 ×). A = non-treated control group; B = vehicle-treated control group, and C = TCA-treated group 
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HDAC inhibitors alter extracellular matrix 
expression to promote cartilage growth by 
enhancing proteoglycan synthesis [19]. The 
HDAC inhibitor, TCA, enhances wound repair by 
increasing the acetylation of lysine in wound 
keratinocytes [16].TCA also accelerates 
embryonic development and stem cell 
differentiation in addition to possessing strong 
anti-inflammatory and anti-cancer properties [11–
15]. Among its mechanisms of action is a 
decrease in the expression of the 
metalloproteinase enzyme and the inhibition of 
cytokine stimulation. In our study, TCA was 
topically applied to the region of the perichondrial 
graft. TCA-stimulated neochondrogenesis was 
then determined by histological examination of 
cartilage tissue sections. Several compounds 
that promote chondrocyte differentiation and 
enhance graft thickness have been shown to 
stimulate cartilage regeneration in perichondrial 
grafts [20]. In this study, topical application of 
TCA significantly (p < 0.01) increased the 
thickness of the cartilage associated with the 
perichondrial graft compared to the control 
groups. Histological analysis of the TCA-treated 
graft showed increased neochondrogenesis.  
 
Further investigations are needed to determine 
the optimal dose of TCA in cartilage regeneration 
and to examine possible side effects. Additional 
studies are also needed to assess the roles of 
the various factors that participate in modulating 




Topical application of the HDAC inhibitor TCA 
enhances chondrocyte proliferation and 
differentiation and, thus, neochondrogenesis 
from a perichondrial graft. Furthermore, the 
findings of this study will be useful in 
understanding the role of trichostatin A in renal 
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